Apr 9, 2020 | Blog, News, Stem Cell News, Uses for Placenta
A small cohort of six critically ill COVID-19 patients hospitalised in Israel have been treated with a placenta-based cell-therapy and have all survived, according to initial data. Pluristem, a company based in Haifa who specialise in the development of human...
Mar 20, 2020 | Blog, News, Stem Cell News, Uses for Cord Blood, Uses for Cord Tissue
According to a recent study, a critically ill patient infected with the new coronavirus has made an astounding recovery after receiving umbilical cord stem cell therapy. What does the study say? After contracting COVID-19, the 65-year-old woman was reportedly...
Mar 10, 2020 | Blog, News, Stem Cell News, Uses for Cord Blood, Uses for Cord Tissue
The outbreak of a new coronavirus, COVID-19, has prompted many expectant parents to wonder whether it can pass from mother to child during pregnancy. Until recently, limited information was available regarding the effects of COVID-19 on pregnant women and their...
Feb 26, 2020 | Blog, News, Stem Cell News, Uses for Cord Blood, Uses for Cord Tissue
The World Health Organisation (WHO) has declared Coronavirus (aka COVID-19) a “public health emergency of international concern”. With the number of cases continuing to increase and no vaccine or specific antiviral treatment currently available, finding a safe and...
Dec 12, 2019 | Blog, News
You may have heard about the Cells4Life ASA ruling on some claims we make in our marketing materials. Specifically, the claim that our TotiCyte processing method preserves 3 times more stem cells than our competitor’s systems. This claim is based on extensive...
Aug 28, 2019 | Blog, News
This month, we celebrate achieving AABB accreditation – a globally renowned certification that recognises standards, practices and quality management in the collection, processing and storage of cord blood. This is just the latest quality standard that we’ve attained....